Growth Metrics

Standard Biotools (LAB) Capital Expenditures Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.64%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.49%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 10.17%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.81%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.35%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.08%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn -31.90%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -31.90%
Dec 31, 2025 -124.00%
Sep 30, 2025 -11.17%
Jun 30, 2025 26.24%
Mar 31, 2025 79.90%
Dec 31, 2024 20.69%
Sep 30, 2024 -28.85%
Jun 30, 2024 -44.11%
Mar 31, 2024 -51.68%
Dec 31, 2023 -31.18%
Sep 30, 2023 38.72%
Jun 30, 2023 9.34%
Mar 31, 2023 -0.65%
Dec 31, 2022 14.73%
Sep 30, 2022 -2.07%
Jun 30, 2022 30.82%
Mar 31, 2022 48.32%
Dec 31, 2021 192.40%
Sep 30, 2021 301.35%
Jun 30, 2021 424.26%
Mar 31, 2021 347.99%
Dec 31, 2020 291.82%
Sep 30, 2020 -15.10%
Jun 30, 2020 65.27%
Mar 31, 2020 14.18%
Dec 31, 2019 -10.35%
Sep 30, 2019 -7.65%
Jun 30, 2019 -34.89%
Mar 31, 2019 -38.51%
Dec 31, 2018 -75.95%
Sep 30, 2018 -5.55%
Jun 30, 2018 -61.98%
Mar 31, 2018 -56.08%
Dec 31, 2017 -50.68%
Sep 30, 2017 -25.80%
Jun 30, 2017 -62.76%
Mar 31, 2017 -27.46%
Dec 31, 2016 -28.28%
Sep 30, 2016 37.81%
Jun 30, 2016 92.14%
Mar 31, 2016 17.90%
Dec 31, 2015 23.49%
Sep 30, 2015 -14.95%
Jun 30, 2015 18.50%
Mar 31, 2015 31.80%
Dec 31, 2014 29.77%
Sep 30, 2014 68.59%
Jun 30, 2014 77.23%
Mar 31, 2014 101.99%
Dec 31, 2013 66.30%
Sep 30, 2013 11.43%